These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 39050733)

  • 1. Understanding the impact of
    Lenk R; Kleindienst W; Szabó GT; Baiersdörfer M; Boros G; Keller JM; Mahiny AJ; Vlatkovic I
    Front Mol Biosci; 2024; 11():1426129. PubMed ID: 39050733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of linearized template plasmid DNA decreases double-stranded RNA formation during IVT reaction.
    Martínez J; Lampaya V; Larraga A; Magallón H; Casabona D
    Front Mol Biosci; 2023; 10():1248511. PubMed ID: 37842641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineered mRNAs With Stable Structures Minimize Double-stranded RNA Formation and Increase Protein Expression.
    Qin Q; Yan H; Gao W; Cao R; Liu G; Zhang X; Wang N; Zuo W; Yuan L; Gao P; Liu Q
    J Mol Biol; 2024 Oct; 436(22):168822. PubMed ID: 39427983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-stranded RNA reduction by chaotropic agents during
    Piao X; Yadav V; Wang E; Chang W; Tau L; Lindenmuth BE; Wang SX
    Mol Ther Nucleic Acids; 2022 Sep; 29():618-624. PubMed ID: 36090758
    [No Abstract]   [Full Text] [Related]  

  • 5. Recent Advances and Innovations in the Preparation and Purification of In Vitro-Transcribed-mRNA-Based Molecules.
    Zhang J; Liu Y; Li C; Xiao Q; Zhang D; Chen Y; Rosenecker J; Ding X; Guan S
    Pharmaceutics; 2023 Aug; 15(9):. PubMed ID: 37765153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Facile Method for the Removal of dsRNA Contaminant from In Vitro-Transcribed mRNA.
    Baiersdörfer M; Boros G; Muramatsu H; Mahiny A; Vlatkovic I; Sahin U; Karikó K
    Mol Ther Nucleic Acids; 2019 Apr; 15():26-35. PubMed ID: 30933724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of in vitro transcription conditions on yield of high quality messenger and self-amplifying RNA.
    Popova PG; Lagace MA; Tang G; Blakney AK
    Eur J Pharm Biopharm; 2024 May; 198():114247. PubMed ID: 38462138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An engineered T7 RNA polymerase for efficient co-transcriptional capping with reduced dsRNA byproducts in mRNA synthesis.
    Miller M; Alvizo O; Baskerville S; Chintala A; Chng C; Dassie J; Dorigatti J; Huisman G; Jenne S; Kadam S; Leatherbury N; Lutz S; Mayo M; Mukherjee A; Sero A; Sundseth S; Penfield J; Riggins J; Zhang X
    Faraday Discuss; 2024 Sep; 252(0):431-449. PubMed ID: 38832894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesoporous Silica Particle as an RNA Adsorbent for Facile Purification of In Vitro-Transcribed RNA.
    Cho E; Namgung J; Lee JS; Jang J; Jun BH; Kim DE
    Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA sensor response in HeLa cells for transfected mRNAs prepared
    Nagaraj S; Stankiewicz-Drogon A; Darzynkiewicz E; Grzela R
    Front Bioeng Biotechnol; 2022; 10():1017934. PubMed ID: 36406230
    [No Abstract]   [Full Text] [Related]  

  • 11. An engineered T7 RNA polymerase that produces mRNA free of immunostimulatory byproducts.
    Dousis A; Ravichandran K; Hobert EM; Moore MJ; Rabideau AE
    Nat Biotechnol; 2023 Apr; 41(4):560-568. PubMed ID: 36357718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of low immunogenicity RNA with high-temperature in vitro transcription.
    Wu MZ; Asahara H; Tzertzinis G; Roy B
    RNA; 2020 Mar; 26(3):345-360. PubMed ID: 31900329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urea supplementation improves mRNA in vitro transcription by decreasing both shorter and longer RNA byproducts.
    Francis C; Frida J P; Thanh-Huong B; Alicja M; Artem K; Jérémie P; Sven Even B
    RNA Biol; 2024 Jan; 21(1):1-6. PubMed ID: 38411163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective Synthesis of mRNA during In Vitro Transcription with Fewer Impurities Produced.
    He W; Geng Q; Ji G; Li J; Wang D; He Y; Jin Q; Ye J
    Molecules; 2024 Oct; 29(19):. PubMed ID: 39407643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Immunotherapy Application of LNP-mRNA: Maximizing Efficacy and Safety.
    Vlatkovic I
    Biomedicines; 2021 May; 9(5):. PubMed ID: 34068715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Messenger RNA chromatographic purification: advances and challenges.
    Feng X; Su Z; Cheng Y; Ma G; Zhang S
    J Chromatogr A; 2023 Sep; 1707():464321. PubMed ID: 37639849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mRNA-based therapies: Preclinical and clinical applications.
    Qureischi M; Mohr J; Arellano-Viera E; Knudsen SE; Vohidov F; Garitano-Trojaola A
    Int Rev Cell Mol Biol; 2022; 372():1-54. PubMed ID: 36064262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding Viral dsRNA-Mediated Innate Immune Responses at the Cellular Level Using a Rainbow Trout Model.
    Poynter SJ; DeWitte-Orr SJ
    Front Immunol; 2018; 9():829. PubMed ID: 29740439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a capillary zone electrophoresis method to monitor magnesium ion consumption during in vitro transcription for mRNA production.
    Wang Y; Li L; Sutton AT; Tu Q; Zhao K; Wen E; Osborn J; Singh A; Gunsch MJ; Rustandi RR; Foley D; He Y
    Anal Bioanal Chem; 2024 May; 416(12):2941-2949. PubMed ID: 38594392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IVT-mRNA reprogramming of myeloid cells for cancer immunotherapy.
    Jolly KJ; Zhang F
    Adv Pharmacol; 2024; 100():247-288. PubMed ID: 39034054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.